Company Profile
GloboMax LLC, co-founded by David Young, Pharm.D., Ph.D., and Keith Chan, Ph.D., is an innovative Contract Research Organization (CRO) offering full pharmaceutical product development services. Our goal is to develop a scientific partnership with each client, utilizing our knowledge, skill and experience to assist our partners in every step of drug development, from conception to approval.
Drs. Young and Chan have 33 years of industrial, regulatory and pharmaceutical research experience combined. Both are established collaborators with the pharmaceutical industry and regulatory agencies. GloboMax has renowned experts in the fields of pharmacokinetics, statistical/database management, and regulatory requirements. William Gillespie, Ph.D., leads our scientific team in the development of innovative research methodologies.
Our steadfast ties with scientific peers and other contract research organizations enable GloboMax LLC to offer full drug development resources to our clients. We are committed to providing high quality and timely services, while fulfilling regulatory requirements and utilizing up-to-date scientific advancements.
GloboMax LLC is conveniently located:
15 minutes south of Baltimore
5 minutes south of Baltimore-Washington International (BWI) Airport
30 minutes north of Washington D.C.
40 minutes northeast of the FDA in Rockville, Maryland |
